RET and multiple endocrine neoplasia type 1: After exclusion of 32 patients (4 with CKD, 23 with incomplete patient records, 2 with tertiary hyperparathyroidism, 1 MEN1 with parathyroid hyperplasia and 2 MEN2A), data from 130 patients were analyzed.